Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€246.90
30.01.22
€270.00
30.01.23
-9.98%
31.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
Henry Schein Inc.

Start price
Target price
Perf. (%)
€67.50
29.09.21
€65.00
29.09.22
0.87%
30.09.22

Could be worthwhile Investment >10% per year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€390.10
20.10.21
€460.00
31.12.23
25.56%
01.09.22

Could be very worthwhile Investment >20% year
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€100.15
26.08.21
-
26.08.22
-2.84%
26.08.22

buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€299.10
21.08.21
€325.00
21.08.22
-10.60%
22.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€396.30
08.07.21
-
08.07.22
-50.25%
08.07.22

buy
Align Technology

Start price
Target price
Perf. (%)
€513.80
08.07.21
-
08.07.22
-50.59%
08.07.22

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€348.40
08.07.21
-
08.07.22
44.86%
08.07.22

buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€439.20
08.07.21
-
08.07.22
23.13%
08.07.22

buy
Medtronic plc

Start price
Target price
Perf. (%)
€107.60
08.07.21
€130.00
08.07.22
-18.17%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Medtronic plc

Start price
Target price
Perf. (%)
€107.60
08.07.21
-
08.07.22
-18.17%
08.07.22

buy
Anthem Inc.

Start price
Target price
Perf. (%)
€363.90
20.10.21
€400.00
31.12.23
26.90%
28.06.22

Could be very worthwhile Investment >20% year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€373.45
20.10.21
€450.00
31.12.23
28.49%
28.06.22

Could be very worthwhile Investment >20% year
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€49.93
07.06.21
€55.00
07.06.22
42.14%
08.06.22

Could be worthwhile Investment >10% per year
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€488.40
15.06.21
-
15.06.22
-27.06%
21.05.22

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€160.00
09.09.21
-
09.09.22
-2.97%
10.03.22

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Illumina Inc.

Start price
Target price
Perf. (%)
€364.50
11.01.22
-
11.01.23
-8.29%
21.01.22

Probably not worthwhile Investment